Esketamine (trade name Spravato) has been approved for adults with severe depression, which is used in combination with an oral antidepressant as follows:
- ✓ Approved for adults with severe depression;
- ✓ Used in combination with an oral antidepressant;
- ✓ Administered under medical supervision in a clinical setting;
- ✓ Typically prescribed when other treatments haven’t been effective;
- ✓ Helps reduce symptoms of treatment-resistant depression;
- ✓ Requires ongoing monitoring for side effects and response;
- ✓ Offers a new option for patients not responding to traditional therapies.
In depression, sad feelings and negative thoughts persist and overshadow actions and thoughts. Depression can occur without a triggering event or identifiable reason. Those affected often feel as if they are stuck in a deep hole. They experience themselves as joyless and lacking in motivation, suffer from strong self-doubt and feel worthless.
Everyday activities, work or learning are difficult; friends, family and hobbies are neglected. Many sufferers have sleep disturbances. Sometimes depression occurs in phases, meaning there are longer symptom-free periods between depressive episodes. During severe episodes, thoughts of suicide may arise.
There are various treatment options available for depression. The most important are psychotherapy such as cognitive behavioral therapy and medication. In contrast to the classic antidepressants, Spravato is said to work within hours and reduce the symptoms of depression quickly.
What is Spravato and what is it used for?
Spravato is a nasal spray containing the active ingredient esketamine, the enantiomerically pure form of the racemic anesthetic ketamine. The drug is approved in combination with an SSRI or SNRI for adults with treatment-resistant major depressive disorder who have failed at least two different antidepressant therapies for their current moderate to severe depressive episode.
In addition, Spravato is indicated in combination with oral antidepressant therapy in adult patients with a moderate to severe major depressive episode as an acute short-term treatment for the rapid reduction of depressive symptoms that, in the judgment of a physician, constitute a psychiatric emergency.
How is Spravato used?
Spravato is administered nasally under the direct supervision of a healthcare professional and is available as a 28 mg nasal spray solution. The patient’s blood pressure must be measured prior to use. Spravato should not be used if elevated blood pressure is present or if elevated intracranial pressure poses a serious risk.
Book a consultation to see if Spravato is right for you—safe, supervised care starts here.
After administration of Spravato, blood pressure should be monitored approximately 40 minutes and again thereafter as clinically appropriate. Because of the potential for sedation, dissociation, and increased blood pressure, patients must be monitored by medical professionals until the patient is clinically stable enough to be discharged.
How does Spravato work?
The mechanism of action leading to esketamine’s antidepressant effect is largely unknown. Esketamine works by affecting certain brain chemicals linked to mood. It blocks a specific brain receptor, which leads to a short-term increase in a chemical called glutamate. This helps improve communication between brain cells and boosts signals that support brain health and emotional balance – leading to relief from depression symptoms.
This mechanism may contribute to the restoration of synaptic function in brain regions responsible for mood and emotion regulation. According to the CHMP, the benefits of Spravato are the ability to reduce a broad spectrum of depressive symptoms in patients with a moderate to severe depressive episode.
Start Your Journey to Wellness
Explore the benefits and risks of Spravato treatment for severe depression
Take the first step toward relief from severe depression today—book your appointment now.
Call: (469)-868-6250Spravato - Advantages and disadvantages
Spravato offers new hope for adults struggling with treatment-resistant depression. Like any medication, it comes with both potential benefits and important considerations.
Advantages of Spravato
🕒 Rapid Symptom Relief
Unlike many traditional antidepressants that can take weeks or even months to show effects, Spravato can provide a significant reduction in depressive symptoms within hours, often as quickly as 24 hours after the first dose. This quick action can be crucial for individuals experiencing severe or debilitating depression.
🛡️ Effective for Treatment-Resistant Depression (TRD)
Spravato is specifically FDA-approved for adults with TRD, meaning it’s designed for people who haven’t responded adequately to at least two other antidepressant treatments. It offers a new mechanism of action that can be effective when other medications have failed.
🧠 Novel Mechanism of Action
Spravato works differently than conventional antidepressants. While traditional antidepressants primarily target neurotransmitters like serotonin, norepinephrine, and dopamine, Spravato primarily affects the glutamate system in the brain, leading to increased neural activity and potentially promoting neuroplasticity (the brain’s ability to form new connections).
💭 Potential for Reduced Suicidal Thoughts
For individuals with major depressive disorder (MDD) who have acute suicidal ideation or behavior, Spravato has demonstrated the ability to rapidly reduce these thoughts, offering critical and potentially life-saving support.
🏥 Administered Under Supervision
Spravato is administered as a nasal spray in a certified healthcare setting under medical supervision. This ensures that patients are monitored for potential side effects and receive immediate support if needed, enhancing safety.
💊 Can Complement Oral Antidepressants
Spravato is typically used in conjunction with an oral antidepressant, providing a multi-faceted approach to treatment and potentially amplifying overall effectiveness.
🔄 Improved Neuroplasticity
Research suggests that Spravato may promote neuroplasticity, helping the brain to form and reorganize synaptic connections. This can contribute to long-term improvements in mood and cognitive function by helping to repair damaged neural pathways associated with depression.
Disadvantages of Spravato
✓ Must be administered in a clinical setting under supervision;
✓ May cause side effects such as dizziness, nausea, or dissociation;
✓ Can temporarily raise blood pressure;
✓ Not recommended for individuals with uncontrolled hypertension or certain heart conditions;
✓ Requires patients to stay at the clinic for monitoring after each dose;
✓ Can be costly and may not be covered by all insurance plans;
✓ Long-term safety and effectiveness are still being studied;
✓ May carry risk of misuse or dependence in some individuals.
Contraindications
Spravato should not be used if:
- ✓ You have a history of aneurysm or blood vessel abnormalities in the brain;
- ✓ You have uncontrolled high blood pressure;
- ✓ You have a history of intracerebral hemorrhage (bleeding in the brain);
- ✓ You are allergic to esketamine or any of its ingredients;
- ✓ You are pregnant or planning to become pregnant without medical approval;
- ✓ You are breastfeeding, unless advised otherwise by your doctor;
- ✓ You have a condition that increases pressure inside the skull (intracranial pressure);
- ✓ You have severe liver impairment without medical clearance.
Side effects
The most common side effects when using Spravato are:
- ✓ Dizziness or lightheadedness;
- ✓ Nausea or vomiting;
- ✓ Feeling disconnected or dissociation;
- ✓ Increased blood pressure;
- ✓ Headache;
- ✓ Drowsiness or fatigue;
- ✓ Anxiety or restlessness;
- ✓ Changes in taste or sensation;
- ✓ Nasal discomfort or irritation;
- ✓ Impaired coordination or attention.
❗ Warnings
The following warnings should be observed when using esketamine nasal spray:
- ✓ Must be administered under direct medical supervision;
- ✓ Monitor blood pressure before and after each treatment session;
- ✓ Avoid driving or operating machinery until the next day after dosing;
- ✓ Use caution in patients with a history of substance abuse or dependence;
- ✓ May cause short-term dissociation or confusion;
- ✓ Not recommended during pregnancy unless clearly needed;
- ✓ Breastfeeding should be avoided unless approved by a physician;
- ✓ Report any unusual psychological or physical symptoms immediately;
- ✓ Continued use requires ongoing evaluation of benefits vs. risks.
Interactions
The following compounds may interact when used concomitantly with esketamine (Spravato):
- ✓ Central nervous system (CNS) depressants, such as benzodiazepines and opioids;
- ✓ Alcohol, which may intensify sedation or dissociation;
- ✓ Monoamine oxidase inhibitors (MAOIs);
- ✓ Stimulant medications (e.g., amphetamines);
- ✓ Antidepressants, particularly SSRIs or SNRIs, when not monitored closely;
- ✓ Medications that increase blood pressure;
- ✓ Drugs affecting liver enzymes (CYP2B6, CYP3A4) that may alter esketamine metabolism;
- ✓ Any sedatives or sleep aids.
✅ Conclusion: Is Spravato Right for You?
Spravato represents a promising advancement in the treatment of severe and treatment-resistant depression, offering rapid relief where traditional antidepressants may fall short. With its unique mechanism of action and supervised administration, it provides a safe and effective option for eligible patients.
However, due to potential side effects, contraindications, and the need for clinical oversight, Spravato may not be suitable for everyone. So, if you or a loved one is struggling with persistent depression, consult with a qualified healthcare provider to determine if Spravato is the right treatment choice for your needs.
Frequently Asked Questions (FAQs) About Spravato
What is Spravato and how does it treat severe depression?
Spravato is a nasal spray containing esketamine, approved for adults with treatment-resistant depression. It works by targeting brain receptors to quickly reduce depressive symptoms, often within hours, unlike traditional antidepressants.
Who is eligible to use Spravato for depression treatment?
Spravato is prescribed for adults with moderate to severe major depressive disorder who have not responded to at least two different antidepressant therapies. It is used alongside an oral antidepressant under medical supervision.
How is Spravato administered and monitored?
Spravato is given as a 28 mg nasal spray in a clinical setting under direct supervision. Patients must have their blood pressure monitored before and after each session and stay in the clinic until medically stable due to potential side effects.
What are the main advantages and risks of using Spravato?
Spravato offers rapid relief from depression symptoms and may reduce suicidal thoughts, but it requires clinical supervision and can cause side effects like dizziness, nausea, increased blood pressure, and dissociation. Long-term safety is still being studied.
Are there any contraindications or precautions for Spravato treatment?
Yes, Spravato should not be used by patients with uncontrolled high blood pressure, history of brain aneurysms, intracranial pressure, allergies to esketamine, or during pregnancy unless approved by a doctor. Close monitoring and avoiding interactions with certain medications are essential.
